Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations

W. Abida, A. H. Bryce, N. J. Vogelzang, R. J. Amato, I. Percent, J. D. Shapiro, R. McDermott, A. Hussain, A. Patnaik, D. Petrylak, C. J. Ryan, T. Stanton, J. Zhang, A. D. Simmons, D. Despain, M. Collins, T. Golsorskhi, H. I. Scher, S. Chowdhury

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii272
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this